Chen Ruoyu 4
4 · GYRE THERAPEUTICS, INC. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Chen Ruoyu
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-07+50,000→ 50,000 totalExercise: $7.31Exp: 2036-01-07→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 50,000 shares of the Issuer's common stock, 25% of which will vest on January 7, 2027, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.